Results 111 to 120 of about 4,909 (178)

Safety of BromAc<sup>®</sup> with Mitomycin C during hyperthermic intraperitoneal chemotherapy (HIPEC): a preclinical study. [PDF]

open access: yesAm J Cancer Res
Mekkawy AH   +9 more
europepmc   +1 more source

Cytoreductive Surgery (CS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Postoperative Evolution, Adverse Outcomes and Perioperative Risk Factors. [PDF]

open access: yesHealthcare (Basel)
Valencia-Sola L   +5 more
europepmc   +1 more source

CD8 + T-cells restrict the development of peritoneal metastasis and support the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC). [PDF]

open access: yesSci Rep
Roth L   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy